Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREOB versus bone autograft in non-infected hypotrophic non-union fractures
2011-005584-24Phase 3Completed
- Sponsor
- BioSenic
- Start
- Feb 2012
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of PREOB in fracture nonunion (2 arms), sponsored by BioSenic. Primary endpoints: Global patient evaluation and Radiological improvement. Started Feb 2012; status: completed.
02
Drugs
PREOB
03
Conditions
fracture nonunion
Beyond the preview
Go deeper on 2011-005584-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005584-24.